GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eli Lilly and Co (XBUL:LLY) » Definitions » E10

Eli Lilly and Co (XBUL:LLY) E10 : лв5.78 (As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Eli Lilly and Co E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Eli Lilly and Co's adjusted earnings per share data for the three months ended in Dec. 2024 was лв8.840. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is лв5.78 for the trailing ten years ended in Dec. 2024.

During the past 12 months, Eli Lilly and Co's average E10 Growth Rate was 20.40% per year. During the past 3 years, the average E10 Growth Rate was 11.60% per year. During the past 5 years, the average E10 Growth Rate was 9.60% per year. During the past 10 years, the average E10 Growth Rate was 7.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Eli Lilly and Co was 13.50% per year. The lowest was -2.70% per year. And the median was 5.30% per year.

As of today (2025-03-25), Eli Lilly and Co's current stock price is лв850.20. Eli Lilly and Co's E10 for the quarter that ended in Dec. 2024 was лв5.78. Eli Lilly and Co's Shiller PE Ratio of today is 147.09.

During the past 13 years, the highest Shiller PE Ratio of Eli Lilly and Co was 172.05. The lowest was 23.03. And the median was 39.14.


Eli Lilly and Co E10 Historical Data

The historical data trend for Eli Lilly and Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eli Lilly and Co E10 Chart

Eli Lilly and Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 5.78

Eli Lilly and Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 4.97 5.23 5.78

Competitive Comparison of Eli Lilly and Co's E10

For the Drug Manufacturers - General subindustry, Eli Lilly and Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eli Lilly and Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Eli Lilly and Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Eli Lilly and Co's Shiller PE Ratio falls into.



Eli Lilly and Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Eli Lilly and Co's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=8.84/133.1571*133.1571
=8.840

Current CPI (Dec. 2024) = 133.1571.

Eli Lilly and Co Quarterly Data

per share eps CPI Adj_EPS
201503 0.906 99.621 1.211
201506 1.014 100.684 1.341
201509 1.359 100.392 1.803
201512 0.784 99.792 1.046
201603 0.743 100.470 0.985
201606 1.286 101.688 1.684
201609 1.322 101.861 1.728
201612 1.270 101.863 1.660
201703 -0.181 102.862 -0.234
201706 1.721 103.349 2.217
201709 0.960 104.136 1.228
201712 -2.862 104.011 -3.664
201803 2.101 105.290 2.657
201806 -0.453 106.317 -0.567
201809 2.029 106.507 2.537
201812 1.928 105.998 2.422
201903 7.808 107.251 9.694
201906 2.609 108.070 3.215
201909 2.482 108.329 3.051
201912 2.830 108.420 3.476
202003 2.898 108.902 3.543
202006 2.808 108.767 3.438
202009 2.409 109.815 2.921
202012 4.009 109.897 4.858
202103 2.699 111.754 3.216
202106 2.772 114.631 3.220
202109 2.210 115.734 2.543
202112 3.279 117.630 3.712
202203 3.804 121.301 4.176
202206 1.902 125.017 2.026
202209 2.917 125.227 3.102
202212 3.694 125.222 3.928
202303 2.699 127.348 2.822
202306 3.532 128.729 3.654
202309 -0.109 129.860 -0.112
202312 4.384 129.419 4.511
202403 4.493 131.776 4.540
202406 5.942 132.554 5.969
202409 1.938 133.029 1.940
202412 8.840 133.157 8.840

Add all the adjusted EPS together and divide 10 will get our e10.


Eli Lilly and Co  (XBUL:LLY) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Eli Lilly and Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=850.20/5.78
=147.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Eli Lilly and Co was 172.05. The lowest was 23.03. And the median was 39.14.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Eli Lilly and Co E10 Related Terms

Thank you for viewing the detailed overview of Eli Lilly and Co's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Eli Lilly and Co Business Description

Address
Lilly Corporate Center, Indianapolis, IN, USA, 46285
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.